---
figid: PMC4673168__oncotarget-06-22348-g005
figlink: /pmc/articles/PMC4673168/figure/F5/
number: Figure 5
caption: A. Class I pan-negative melanomas are primarily driven by the MAPK pathway
  and express generally robust levels of the ERK1/2 phosphatase, DUSP4, but have no
  endogenously active ERBB receptors. Class I melanomas behave similarly to BRAF V600-mutant
  melanomas in that they are highly sensitive to MEK1/2 inhibition. B. Class II pan-negative
  melanomas are activated by ERBB receptors, which activate both MAPK and PI3K/AKT
  signaling, making them less susceptible to MEK1/2 inhibition than Class I melanomas,
  but more susceptible to combined inhibition of ERBBs and MEK1/2. A potential mechanism
  for the ERBB activity in Class II's is the relative lack of DUSP4 expression, presumably
  allowing ERK1/2-mediated transcription of ERBB ligands such as amphiregulin (AREG).
  C. This pie chart displays the breakdown of driver events that sustain melanoma.
  Our study has shown that 4 pan-negative melanomas display ERBB activation (25%),
  but only 3 of those (18.8%) were sensitive to ERBB inhibition which can be extrapolated
  to ~6% of all melanomas.
pmcid: PMC4673168
papertitle: ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset
  of driver-negative melanoma.
reftext: Katherine E. Hutchinson, et al. Oncotarget. 2015 Sep 8;6(26):22348-22360.
pmc_ranked_result_index: '139832'
pathway_score: 0.7134774
filename: oncotarget-06-22348-g005.jpg
figtitle: ERBB activation modulates sensitivity to MEK1/2 inhibition in a subset of
  driver-negative melanoma
year: '2015'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4673168__oncotarget-06-22348-g005.html
  '@type': Dataset
  description: A. Class I pan-negative melanomas are primarily driven by the MAPK
    pathway and express generally robust levels of the ERK1/2 phosphatase, DUSP4,
    but have no endogenously active ERBB receptors. Class I melanomas behave similarly
    to BRAF V600-mutant melanomas in that they are highly sensitive to MEK1/2 inhibition.
    B. Class II pan-negative melanomas are activated by ERBB receptors, which activate
    both MAPK and PI3K/AKT signaling, making them less susceptible to MEK1/2 inhibition
    than Class I melanomas, but more susceptible to combined inhibition of ERBBs and
    MEK1/2. A potential mechanism for the ERBB activity in Class II's is the relative
    lack of DUSP4 expression, presumably allowing ERK1/2-mediated transcription of
    ERBB ligands such as amphiregulin (AREG). C. This pie chart displays the breakdown
    of driver events that sustain melanoma. Our study has shown that 4 pan-negative
    melanomas display ERBB activation (25%), but only 3 of those (18.8%) were sensitive
    to ERBB inhibition which can be extrapolated to ~6% of all melanomas.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DUSP2
  - EGFR
  - ERBB2
  - NF1
  - NRAS
  - MAPK3
  - MAPK11
  - ERBB4
  - DUSP1
  - MAPK10
  - MAPK9
  - ERBB3
  - MTOR
  - BRAF
  - RAF1
  - DUSP3
  - DUSP4
  - DUSP5
  - DUSP6
  - SOS2
  - PIK3R3
  - MAPK13
  - MAPK1
  - MAP2K1
  - GNA11
  - GRB2
  - KIT
  - MAPK8
  - MAPK14
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - MAP2K2
  - PIK3R6
  - MAPK12
  - AKT1
  - SOS1
  - AREG
  - ARAF
  - PIK3R4
  - HRAS
  - KRAS
  - PIK3CA
  - AKT2
  - AKT3
  - PIK3R5
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP2
  entrez: '1844'
- word: ERBB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: ERBB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: NF1
  symbol: NF1
  source: hgnc_symbol
  hgnc_symbol: NF1
  entrez: '4763'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: ERBB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB4
  entrez: '2066'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP1
  entrez: '1843'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: ERBB
  symbol: ERBB
  source: bioentities_symbol
  hgnc_symbol: ERBB3
  entrez: '2065'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP3
  entrez: '1845'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP4
  entrez: '1846'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP5
  entrez: '1847'
- word: DUSP
  symbol: DUSP
  source: bioentities_symbol
  hgnc_symbol: DUSP6
  entrez: '1848'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS2
  entrez: '6655'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK1/2
  symbol: MEK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: GNA11
  symbol: GNA11
  source: hgnc_symbol
  hgnc_symbol: GNA11
  entrez: '2767'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: KIT
  symbol: KIT
  source: hgnc_symbol
  hgnc_symbol: KIT
  entrez: '3815'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: MEK1/2
  symbol: MEK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Sos
  symbol: SOS
  source: bioentities_symbol
  hgnc_symbol: SOS1
  entrez: '6654'
- word: AREG
  symbol: AREG
  source: hgnc_symbol
  hgnc_symbol: AREG
  entrez: '374'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K/AKT
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
